The Insider Activity Report For Incyte Corporation (INCY): Who’s Selling?


Incyte Corporation (NASDAQ:INCY) finished Friday with an addition of $0.84 to close at $80.32, an upside of 1.06 percent. An average of 855,700 shares of common stock have been traded in the last five days. There was a fall of -$0.80 in the past week, and it reached a new high 15 times over the past 12 months. The last 20 days have seen an average of 1,330,955 shares traded, while the 50-day average volume stands at 1,429,254.

INCY stock has increased by 0.82% in the last month. The company shares reached their 1-month lowest point of $78.87 on 12/30/22. With the stock rallying to its 52-week high on 04/08/22, shares of the company touched a low of $65.07 and a high of $84.86 in 52 weeks. It has reached a new high 17 times so far this year and achieved 9.43% or $6.92 in price. In spite of this, the price is down -5.35% from the 52-week high.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.


Insider Transactions

INCY stock investors should be aware that Incyte Corporation (INCY) stock had its last reported insider trading activity 8 days ago on Dec 23. In this transaction, the insider spent $1,399,739. Principal Accounting Officer, Tray Thomas, disposed of 1,223 shares at a price of $82.16 on Dec 19. The insider now owns more than $100,482 worth of shares. Prior to that, Principal Accounting Officer Tray Thomas went on to Sale 1,564 shares at $83.13 each on Jul 22. An amount of $130,015 was transacted.

Valuation Metrics

Incyte Corporation (INCY) has a trailing price-to-earnings (P/E) ratio of 20.41. The stock’s beta is 0.70. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 5.35, the price-to-book (PB) ratio at 4.23, and the price-to-cash flow ratio at 25.07.

Financial Health

The quick ratio of Incyte Corporation for the three months ended September 29 was 3.80, and the current ratio was 3.80, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.01 and a total debt to equity ratio of 0.01 for the quarter ending September 29. Its gross profit as reported stood at $2.84 billion compared to revenue of $2.99 billion.

Earnings Surprise

For the three-month period that ended September 29, Incyte Corporation had $286.5 million in cash. In the quarter under review, the net income was down than the previous quarter. The company posted a net income of $112.78 million in the quarter, while revenues of $161.43 million were shrunk -61.15%. The analyst consensus anticipated Incyte Corporation’s latest quarter earnings to come in at $0.72 per share, but it turned out to be $0.6, a -16.70% surprise. For the quarter, EBITDA amounted to $155.07 million. Shareholders own equity worth $222.48 million.

Technical Picture

From a technical analysis perspective, let’s take a brief look at Incyte Corporation (INCY) price momentum. RSI 9-day as of the close on 30 December was 46.86%, suggesting the stock is Neutral, with historical volatility in this time frame at 16.69%.

As of today, INCY’s price is $80.04 -0.99% or -$0.80 from its 5-day moving average. INCY is currently trading -0.45% lower than its 20-day SMA and +8.94% higher than its 100-day SMA. However, the stock’s current price level is +15.42% above the SMA50 and +7.67% above the SMA200.

The stochastic %K and %D were 13.92% and 10.35%, respectively, and the average true range (ATR) was 1.42. With the 14-day stochastic at 31.66% and the average true range at 1.49, the RSI (14) stands at 50.73%. The stock has reached -0.64 on the 9-day MACD Oscillator while the 14-day reading was at -1.37.

Analyst Ratings

Guggenheim downgraded Incyte Corporation (NASDAQ: INCY) to a a Neutral rating in its most recent analyst report. Previously, the stock was rated as a Buy. The consensus rating for Incyte Corporation (INCY) among analysts is Overweight. According to current brokerage recommendations, 1 brokerage firm advise that investors sell INCY, while 9 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 2 analysts, while 9 others rate it as a “buy”.

What is INCY’s price target for the next 12 months?

Analysts predict a range of price targets between $63.00 and $123.00, with a median target of $82.50. Taking a look at these predictions, the average price target given by analysts for Incyte Corporation (INCY) stock is $87.00.


Please enter your comment!
Please enter your name here